Wilson's Disease also called hepatolenticular degeneration and progressive lenticular degeneration is an extremely rare genetic disorder that causes copper poisoning in the body. A mutation in the ATP7B gene, which codes for copper transportation, is the main cause of Wilson&rsquo;s Disease.
&nbsp;
The liver filters out excess copper and releases it through urine, in a healthy body. Whereas in Wilson&rsquo;s Disease, the liver cannot remove the extra copper properly. The extra copper then builds up in organs such as the brain, liver, and eyes.&nbsp;
&nbsp;
Wilson's Disease Symptoms
&nbsp;
The symptoms of Wilson's Disease usually include fatigue, lack of appetite, or abdominal pain, jaundice, golden-brown eye discoloration, fluid buildup in the legs or abdomen, problems with speech, swallowing, or physical coordination, and uncontrolled movements or muscle stiffness
&nbsp;
Wilson's Disease Epidemiological Segmentation&nbsp;
&nbsp;
The Epidemiological Segmentation of Wilson's Disease in 7MM from 2018 to 2030 is segmented into:-
&nbsp;
<ul>
<li>Total prevalent cases of Wilson's Disease</li>
<li>Diagnosed prevalent cases of Wilson's Disease</li>
<li>Prevalent cases by clinical manifestation of Wilson's Disease</li>
</ul>
&nbsp;
Wilson's Disease Epidemiological Insights Observed in 2020
&nbsp;
<ul>
<li>The total prevalent population of Wilson's Disease in the 7MM was found to be 35,509.</li>
<li>Japan has the highest prevalence of Wilson's Disease among the 7MM countries.</li>
<li>Among the EU5 countries, Germany had the highest prevalent population of Wilson's Disease whereas Spain had 797 cases of Wilson's Disease.</li>
</ul>
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/wilson-disease-market" target="_blank" rel="noopener noreferrer">Wilson's Disease Market</a>
&nbsp;
The Wilson's Disease therapeutic market is expected to change in the 7MM during the study period (2017&ndash;2030).
&nbsp;
Wilson's Disease Emerging Drugs
&nbsp;
The emerging drugs of the Wilson's Disease market are
&nbsp;
<ul>
<li>ALXN1840</li>
<li>Bis-Choline Tetrathiomolybdate</li>
<li>VTX-801</li>
<li>TETA 4HCL, and others</li>
</ul>
&nbsp;
Wilson's Disease Key Players
&nbsp;
The key players working in the Wilson's Disease market are&nbsp;
&nbsp;
<ul>
<li>Alexion Pharmaceuticals</li>
<li>Vivet Therapeutics</li>
<li>Orphalan, and others</li>
</ul>

Wilson's Disease Market

Wilson's Disease Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape